Logo image of CDLR

CADELER A/S-ADR (CDLR) Stock Fundamental Analysis

NYSE:CDLR - New York Stock Exchange, Inc. - US12738K1097 - ADR - Currency: USD

20.38  +0.31 (+1.54%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CDLR. CDLR was compared to 49 industry peers in the Construction & Engineering industry. While CDLR belongs to the best of the industry regarding profitability, there are concerns on its financial health. CDLR is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CDLR had positive earnings in the past year.
In the past year CDLR had a positive cash flow from operations.
Of the past 5 years CDLR 4 years were profitable.
Of the past 5 years CDLR 4 years had a positive operating cash flow.
CDLR Yearly Net Income VS EBIT VS OCF VS FCFCDLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

CDLR has a Return On Assets of 3.84%. This is comparable to the rest of the industry: CDLR outperforms 57.14% of its industry peers.
Looking at the Return On Equity, with a value of 7.71%, CDLR is in line with its industry, outperforming 57.14% of the companies in the same industry.
CDLR has a Return On Invested Capital (3.76%) which is in line with its industry peers.
CDLR had an Average Return On Invested Capital over the past 3 years of 3.13%. This is significantly below the industry average of 16.67%.
The last Return On Invested Capital (3.76%) for CDLR is above the 3 year average (3.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.84%
ROE 7.71%
ROIC 3.76%
ROA(3y)3.19%
ROA(5y)0.66%
ROE(3y)4.35%
ROE(5y)0.82%
ROIC(3y)3.13%
ROIC(5y)N/A
CDLR Yearly ROA, ROE, ROICCDLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

CDLR has a better Profit Margin (23.95%) than 97.96% of its industry peers.
CDLR's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 27.22%, CDLR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CDLR has grown nicely.
CDLR has a Gross Margin of 48.86%. This is amongst the best in the industry. CDLR outperforms 93.88% of its industry peers.
In the last couple of years the Gross Margin of CDLR has grown nicely.
Industry RankSector Rank
OM 27.22%
PM (TTM) 23.95%
GM 48.86%
OM growth 3Y13.3%
OM growth 5YN/A
PM growth 3Y28.86%
PM growth 5YN/A
GM growth 3Y11.41%
GM growth 5YN/A
CDLR Yearly Profit, Operating, Gross MarginsCDLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CDLR is destroying value.
Compared to 1 year ago, CDLR has about the same amount of shares outstanding.
The number of shares outstanding for CDLR has been increased compared to 5 years ago.
Compared to 1 year ago, CDLR has a worse debt to assets ratio.
CDLR Yearly Shares OutstandingCDLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CDLR Yearly Total Debt VS Total AssetsCDLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that CDLR is in the distress zone and has some risk of bankruptcy.
CDLR's Altman-Z score of 1.10 is on the low side compared to the rest of the industry. CDLR is outperformed by 69.39% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that CDLR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.82, CDLR is in line with its industry, outperforming 46.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACC0.59
WACC6.41%
CDLR Yearly LT Debt VS Equity VS FCFCDLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 1.19 indicates that CDLR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.19, CDLR is in line with its industry, outperforming 40.82% of the companies in the same industry.
CDLR has a Quick Ratio of 1.17. This is a normal value and indicates that CDLR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CDLR (1.17) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.17
CDLR Yearly Current Assets VS Current LiabilitesCDLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

9

3. Growth

3.1 Past

CDLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 269.26%, which is quite impressive.
CDLR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.20% yearly.
Looking at the last year, CDLR shows a very strong growth in Revenue. The Revenue has grown by 128.99%.
The Revenue has been growing by 45.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)269.26%
EPS 3Y57.2%
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)128.99%
Revenue growth 3Y59.82%
Revenue growth 5Y45.32%
Sales Q2Q%243.46%

3.2 Future

Based on estimates for the next years, CDLR will show a very strong growth in Earnings Per Share. The EPS will grow by 43.41% on average per year.
CDLR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.40% yearly.
EPS Next Y139.2%
EPS Next 2Y123.93%
EPS Next 3Y97.52%
EPS Next 5Y43.41%
Revenue Next Year102.14%
Revenue Next 2Y97.18%
Revenue Next 3Y64.14%
Revenue Next 5Y44.4%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CDLR Yearly Revenue VS EstimatesCDLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CDLR Yearly EPS VS EstimatesCDLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.87, the valuation of CDLR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CDLR is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CDLR to the average of the S&P500 Index (27.41), we can say CDLR is valued inline with the index average.
CDLR is valuated reasonably with a Price/Forward Earnings ratio of 8.92.
Based on the Price/Forward Earnings ratio, CDLR is valued cheaply inside the industry as 97.96% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, CDLR is valued rather cheaply.
Industry RankSector Rank
PE 32.87
Fwd PE 8.92
CDLR Price Earnings VS Forward Price EarningsCDLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

69.39% of the companies in the same industry are more expensive than CDLR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.49
CDLR Per share dataCDLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

CDLR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CDLR may justify a higher PE ratio.
CDLR's earnings are expected to grow with 97.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y123.93%
EPS Next 3Y97.52%

0

5. Dividend

5.1 Amount

No dividends for CDLR!.
Industry RankSector Rank
Dividend Yield N/A

CADELER A/S-ADR

NYSE:CDLR (7/11/2025, 8:04:00 PM)

20.38

+0.31 (+1.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-26 2025-08-26
Inst Owners35.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.79B
Analysts87.37
Price Target24.19 (18.69%)
Short Float %1.28%
Short Ratio12.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.58%
Min EPS beat(2)-75.73%
Max EPS beat(2)52.57%
EPS beat(4)2
Avg EPS beat(4)0.39%
Min EPS beat(4)-75.73%
Max EPS beat(4)52.57%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.41%
Min Revenue beat(2)-16.28%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-6.52%
Min Revenue beat(4)-16.28%
Max Revenue beat(4)-0.53%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.66%
PT rev (3m)6.98%
EPS NQ rev (1m)-6.67%
EPS NQ rev (3m)-42.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.55%
Revenue NQ rev (1m)-1.9%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 32.87
Fwd PE 8.92
P/S 3.87
P/FCF N/A
P/OCF 15.23
P/B 1.25
P/tB 1.27
EV/EBITDA 14.49
EPS(TTM)0.62
EY3.04%
EPS(NY)2.28
Fwd EY11.21%
FCF(TTM)-11.74
FCFYN/A
OCF(TTM)1.34
OCFY6.57%
SpS5.26
BVpS16.34
TBVpS16.09
PEG (NY)0.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.84%
ROE 7.71%
ROCE 4.75%
ROIC 3.76%
ROICexc 3.92%
ROICexgc 3.95%
OM 27.22%
PM (TTM) 23.95%
GM 48.86%
FCFM N/A
ROA(3y)3.19%
ROA(5y)0.66%
ROE(3y)4.35%
ROE(5y)0.82%
ROIC(3y)3.13%
ROIC(5y)N/A
ROICexc(3y)3.24%
ROICexc(5y)N/A
ROICexgc(3y)3.26%
ROICexgc(5y)N/A
ROCE(3y)3.96%
ROCE(5y)N/A
ROICexcg growth 3Y7.82%
ROICexcg growth 5YN/A
ROICexc growth 3Y7.49%
ROICexc growth 5YN/A
OM growth 3Y13.3%
OM growth 5YN/A
PM growth 3Y28.86%
PM growth 5YN/A
GM growth 3Y11.41%
GM growth 5YN/A
F-Score6
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Debt/EBITDA 5.82
Cap/Depr 1500.01%
Cap/Sales 248.44%
Interest Coverage 4.88
Cash Conversion 58.05%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.17
Altman-Z 1.1
F-Score6
WACC6.41%
ROIC/WACC0.59
Cap/Depr(3y)789.97%
Cap/Depr(5y)1003.15%
Cap/Sales(3y)173.5%
Cap/Sales(5y)420.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)269.26%
EPS 3Y57.2%
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y139.2%
EPS Next 2Y123.93%
EPS Next 3Y97.52%
EPS Next 5Y43.41%
Revenue 1Y (TTM)128.99%
Revenue growth 3Y59.82%
Revenue growth 5Y45.32%
Sales Q2Q%243.46%
Revenue Next Year102.14%
Revenue Next 2Y97.18%
Revenue Next 3Y64.14%
Revenue Next 5Y44.4%
EBIT growth 1Y257.17%
EBIT growth 3Y81.07%
EBIT growth 5YN/A
EBIT Next Year366.91%
EBIT Next 3Y125.8%
EBIT Next 5Y68.2%
FCF growth 1Y-14640.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.89%
OCF growth 3Y45.54%
OCF growth 5YN/A